RaQualia Pharma Inc. (TYO:4579)
Japan flag Japan · Delayed Price · Currency is JPY
725.00
-18.00 (-2.42%)
Nov 18, 2026, 10:14 AM JST

RaQualia Pharma Revenue

RaQualia Pharma had revenue of 895.00M JPY in the quarter ending September 30, 2026, with 15.48% growth. This brings the company's total for the last twelve months to 4.02B, up 31.77% year-over-year. In the year 2025, RaQualia Pharma had annual revenue of 3.98B with 28.07% growth. That makes RaQualia Pharma the 32,490th largest company in the world by revenue and 3,401st in Japan.

Revenue (ttm)
4.02B
Revenue Growth
+31.77%
P/S Ratio
4.81
Revenue / Employee
47.27M
Employees
85
Market Cap
18.87B

Revenue Chart

Revenue by Geography

  • Asia 2.05B 51.5%
  • Japan 1.07B 26.8%
  • United States of America 861.00M 21.6%
Fiscal year ended Dec 31, 2025 See the full RaQualia Pharma breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.98B872.00M28.07%
Dec 31, 20243.11B1.21B63.44%
Dec 31, 20231.90B-1.02B-34.85%
Dec 31, 20222.92B142.00M5.12%
Dec 31, 20212.78B1.67B150.77%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.